Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Selecting the right IRA type for index funds hinges on your tax picture, contribution goals, and retirement timeline.
24,084 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A healthy 65-year-old with a family history of long life confronts Social Security timing beyond the classic break-ev...
Palo Alto Networks leads a broad cybersecurity rally as UBS projects a multibillion-dollar market by 2026, sparking c...
As 2026 brings higher IRMAA thresholds, retirees near the line must plan for steeper Medicare costs. This report expl...
Micron Technology has unleashed a dramatic first half, but the market now eyes a cautious microns stock price predict...
I’ve spent week world’s top AI talks and the takeaway is sharp: talent battles and new pricing models will ripple thr...
Ark Invest discloses a fresh Palantir stake as AI momentum collides with higher yields, prompting debate over whether...
Analysts on Wall Street continue lifting price targets for AMD as AI-enabled datacenters drive revenue growth and exp...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
A veteran portfolio manager says the real crowded trade is hiding in plain sight, far from the Mag 7 narrative. He po...
Three leading egg producers settle with federal and state regulators over alleged price‑fixing, donating 53 million e...
A historic clash over openness in software mirrors today’s AI debate, with investors watching who controls code, data...